David Ristenpart



With a strong background in manufacturing and marketing in Southern California, and having been a co-founder of FuturaGene, Inc. with Dr. Bruno Ruggiero in 2001, David has remained in either an active management role or as a contributing “angel investor” in virtually every commercial venture involving, among others, the Osmotin protein, since its valuation was first conceptualised.


As CFO of 9th Dimension Biotech Inc., David is well positioned to direct the production and commercialisation aspects of 9D’s product pipeline. 


David co-founded 9D with the goal of advancing key technologies to offer tangible solutions to major human health and agricultural issues.